Literature DB >> 12445679

Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves.

Tetsuya Kodama1, Apostolos G Doukas, Michael R Hamblin.   

Abstract

We report on the use of shock waves delivered by a shock-tube to permeabilize cancer cells and potentiate the cytotoxicity of the type-1 ribosome-inactivating protein, saporin. We studied human colorectal cancer HT29 and ovarian cancer OVCAR-5 cells, and used two different cytotoxicity assays, colony formation and loss of mitochondrial activity. A single shock wave and saporin (10(-9) M) produced significant toxicity not seen with either shock wave or drug alone. Increasing the number of shock waves up to five further increased cytotoxicity. Higher toxicity was seen with the clonogenic assay compared to MTT assay. Shock waves may have applications in promoting cytoplasmic delivery of toxins into cancer cells after intratumoral injection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12445679      PMCID: PMC3568984          DOI: 10.1016/s0304-3835(02)00503-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Augmented inhibition of tumor cell proliferation in combined use of electroporation with a plant toxin, saporin.

Authors:  H Mashiba; Y Ozaki; K Matsunaga
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Scavenger-receptor targeted photodynamic therapy.

Authors:  M R Hamblin; J L Miller; B Ortel
Journal:  Photochem Photobiol       Date:  2000-10       Impact factor: 3.421

3.  Cytoplasmic molecular delivery with shock waves: importance of impulse.

Authors:  T Kodama; M R Hamblin; A G Doukas
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

4.  Shock wave permeabilization with ribosome inactivating proteins: a new approach to tumor therapy.

Authors:  M Delius; G Adams
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  Augmentation of antiproliferative and antitumor effect on human cancer cells in combined use of electroporation with a plant toxin, saporin.

Authors:  H Mashiba; Y Ozaki; S Ikuno; K Matsunaga
Journal:  Cancer Biother Radiopharm       Date:  2001-12       Impact factor: 3.099

Review 6.  Monoclonal antibody therapies for lymphomas.

Authors:  K A Foon
Journal:  Cancer J       Date:  2000 Sep-Oct       Impact factor: 3.360

7.  Shock wave-mediated molecular delivery into cells.

Authors:  Tetsuya Kodama; Apostolos G Doukas; Michael R Hamblin
Journal:  Biochim Biophys Acta       Date:  2002-01-30

8.  In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy.

Authors:  P K Selbo; G Sivam; O Fodstad ; K Sandvig; K Berg
Journal:  Int J Cancer       Date:  2001-06-01       Impact factor: 7.396

9.  Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.

Authors:  D J Flavell; D A Boehm; A Noss; S L Warnes; S U Flavell
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

10.  Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.

Authors:  M Del Governatore; M R Hamblin; E E Piccinini; G Ugolini; T Hasan
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

View more
  3 in total

1.  Shockwaves increase T-cell proliferation and IL-2 expression through ATP release, P2X7 receptors, and FAK activation.

Authors:  Tiecheng Yu; Wolfgang G Junger; Changji Yuan; An Jin; Yi Zhao; Xueqing Zheng; Yanjun Zeng; Jianguo Liu
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-04       Impact factor: 4.249

2.  Computational Studies of the Effect of Shock Waves on the Binding of Model Complexes.

Authors:  George A Kaminski
Journal:  J Chem Theory Comput       Date:  2014-09-25       Impact factor: 6.006

3.  Bio fabrication of gold nanoparticles and their combination with chemotherapy and ultrasound for effective treatment of tumors.

Authors:  Mingmei Li
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.